Ron Bentsur
2023 - Nuvectis Pharma
In 2023, Ron Bentsur earned a total compensation of $2.7M as President & Chief Executive Officer at Nuvectis Pharma, a 59% increase compared to previous year.
Compensation breakdown
| Bonus | $508,875 |
|---|---|
| Salary | $615,250 |
| Stock Awards | $1,566,600 |
| Total | $2,690,725 |
Bentsur received $1.6M in stock awards, accounting for 58% of the total pay in 2023.
Bentsur also received $508.9K in bonus and $615.3K in salary.
Rankings
In 2023, Ron Bentsur's compensation ranked 350th out of 2,918 executives tracked by ExecPay. In other words, Bentsur earned more than 88.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 350 out of 2,918 | 88th |
Division Manufacturing | 201 out of 1,608 | 88th |
Major group Chemicals And Allied Products | 139 out of 901 | 85th |
Industry group Drugs | 136 out of 864 | 84th |
Industry Pharmaceutical Preparations | 84 out of 622 | 87th |
Source: SEC filing on April 29, 2024.
Bentsur's colleagues
We found two more compensation records of executives who worked with Ron Bentsur at Nuvectis Pharma in 2023.